KCT0008066尚未招募未知
A prospective, single-center, randomized, controlled, evaluator-blinded, feasibility clinical trial to evaluate efficacy and safety of Pulsed High-Intensity Focused Ultrasound therapy ‘IMD10’ with neoadjuvant FOLFIRINOX in locally advanced pancreatic cancer or borderline resectable pancreatic cancer
IMGT0 个研究点目标入组 30 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 19(Year) 至 84(Year)（—）
- 性别
- All
入选标准
- •1.Adults of age = 19 and <85
- •2.A Person diagnosed with pancreatic ductal adenocarcinoma (PDAC) through biopsy
- •3.Within 4 weeks at the time of screening, who is diagnosed with locally advanced pancreatic cancer (LAPC) or borderline resectable pancreatic cancer (BRPC) by computed tomography (CT) or magnetic resonance imaging (MRI), and who is determined to require neoadjuvant FOLFIRINOX/mFOLFIRINOX regimen.
- •4.Who have one or more measurable lesions on CT or MRI according by response evaluation criteria in solid tumors (RECIST) version 1.1 at the time of screening.
- •5.Persons with karnofsky performance scale (KPS) of 70% or more.
- •6.A person who agrees to medically permitted contraception* during the clinical trial period
- •*Hormonal contraception, intrauterine device, vasectomy, tubal ligation, double blocking method (combined use of blocking methods such as male condom, female condom, cervical cap, diaphragm, and contraceptive sponge), single blocking method using spermicide
- •7.Who voluntarily decides to participate in this clinical trial and has agreed to the Informed Consent Form in writing.
- •8.Who are willing to comply with the clinical trial protocol
排除标准
- •1.The presence of a cystic lesion within pancreatic cancer to be treated with high-intensity focused ultrasound (HIFU) or at the pancreas adjacent to the pancreatic cancer.
- •2.The presence of a wide range of scar or surgical clips observed in the passage through the ultrasonic beam.
- •3.In case proper ultrasound image for HIFU procedure is not visible
- •4.Who are unable to lie down during HIFU application time
- •5.Who has experienced a toxic or hypersensitivity reaction to FOLFIRINOX chemotherapy (oxaliplatin, irinotecan hydrochloride, calcium folinate, fluorouracil)
- •6.Pancreatic cancer patients who have previously been anti-cancer treatment
- •7.At the time of screening, a person who is unsuitable for a clinical trial, because of one or more of the following cardiovascular diseases,
- •?Class III or IV heart failure by classification of the New York Heart Association (NYHA)
- •?Acute coronary syndrome (unstable angina or myocardial infarction) occurring within the last 6 months
- •?Uncontrolled cardiac arrhythmias
- •?Persons judged as clinically significant cardiovascular abnormalities by investigators
- •8.At the time of screening, a person who has or has a history of one or more of the following diseases
- •?Other uncontrolled chronic infectious diseases
- •?Active autoimmune diseases (ex, rheumatoid arthritis, systemic lupus erythematosus, ulcerative colitis, Crohn's disease, multiple sclerosis, ankylosing spondylitis, etc.)
- •?Congenital or acquired immunodeficiency diseases such as cell immunodeficiency syndrome, hypogammaglobulinemia, and dysgammaglobulinemia
- •?Clinically significant mental illness
- •?Patients with a history of malignant tumors other than pancreatic cancer within the past 5 years (However, patients with a history of basal cell or squamous cell skin cancer and non-invasive carcinomas can participate in clinical trial only if properly treated)
- •?A history of major surgery within 4 weeks at the time of screening
- •9.Who have difficulty communicating
- •10.Who are pregnant or breastfeeding
- •11.Who is currently participating in or has participated in clinical trials of other investigational products/investigational devices within 90 days at the time of screening
- •12.etc, When the investigator determines that participation in the clinical trial is inappropriate because it may affect the clinical trial results or ethically
- •? The specific reason shall be write in the case report form
研究者
相似试验
已完成
不适用
Preservation technique of ruptured anterior cruciate ligament (ACL)Anterior cruciate ligament (ACL) injuryInjury, Occupational Diseases, PoisoningSprain and strain involving (anterior)(posterior) cruciate ligament of kneeISRCTN89368687Swiss National Insurance Association (SUVA) (Switzerland)100
招募中
不适用
Applying a high frequency stimulator intended for shoulder pain patientsKCT0002545Chonbuk National University Hospital38
已完成
3 期
A prospective, randomized, single- blind, controlled study to investigate the effect of suplatast tosilate on early- stage idiopathic pulmonary fibrosisIdiopathic pulmonary fibrosisJPRN-UMIN000001567Hiroshima University Hospital, Department of Respiratory Medicine60
招募中
不适用
Effect of stellate ganglion block combined with auricular acupoints on postoperative sleep disturbance in patients with hip arthroplastyITMCTR2100004991the First Affiliated Hospital of Guangzhou University of Chinese Medicine
已完成
不适用
Post marketing study to evaluate safety and efficacy of suture material (MITSUâ?¢ Polyglactin 910) of Meril Endo Surgery Pvt. Ltd in comparision with coated (Vicrylâ?¢ Polyglactin 910) Suture during surgery for closure of surgical incision.CTRI/2017/01/007717Meril EndoSurgery Pvt Ltd122